No guarantee exists, and surgical intervention remains necessary for some individuals after substantial loss
In a study using cultured rat hippocampal neurons, pre-treatment of nerve cells with GLP-1 resulted in a weakened Ca 2+ response to glutamate and weakened membrane depolarization (46)
Why All GLP-1 Drugs Face Lawsuits Despite their differences in active ingredients, manufacturers, and mechanisms, all GLP-1 medications share one critical characteristic that makes them dangerous : The Common Mechanism: Delayed Gastric Emptying Normal Digestion: You eat food Your stomach churns and breaks it down (1-2 hours) Partially digested food moves into the small intestine Nutrients are absorbed Waste continues to the colon On GLP-1 Medications: You eat food The drug dramatically slows stomach muscle contractions Food sits in the stomach for many hours (or days) Delayed movement into small intestine Prolonged fullness leads to appetite suppression and weight loss For Most Patients: This causes temporary fullness and reduced appetite - the intended effect
It directly compared outcomes to both placebo and dulaglutide (1.5 mg), establishing proof of concept
The authors suggested that the reduction in cancer risk may not be mediated by the weight loss but rather by other mechanisms
60 In a meta-analysis by Shi et al., GLP-1RAs significantly reduced AF events compared to metformin, sulfonylurea, insulin and non-sulfonylurea in patients with T2D and were associated with better outcomes compared to other medications
&srotate=0)
.png.jpg)
